Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2).

Yki-Järvinen H, Bergenstal R, Ziemen M, Wardecki M, Muehlen-Bartmer I, Boelle E, Riddle MC; EDITION 2 Study Investigators.

Diabetes Care. 2014 Dec;37(12):3235-43. doi: 10.2337/dc14-0990. Epub 2014 Sep 5.

PMID:
25193531
2.

[Pulmonary Langerhans' cell histiocytosis in adults: an unknown old disease].

Aburto M, Capelastegui A.

Med Clin (Barc). 2014 Nov 18;143(10):444-5. doi: 10.1016/j.medcli.2014.02.020. Epub 2014 Apr 17. Spanish. No abstract available.

PMID:
24747024
3.

Multicentric study on the beta-blocker use and relation with exacerbations in COPD.

Puente-Maestu L, Calle M, Ortega-González A, Fuster A, González C, Márquez-Martín E, Marcos-Rodriguez PJ, Calero C, Rodríguez-Hermosa JL, Malo de Molina R, Aburto M, Sobradillo P, Alcázar B, Tirado-Conde G; GEMEPOC Group.

Respir Med. 2014 May;108(5):737-44. doi: 10.1016/j.rmed.2014.02.009. Epub 2014 Feb 20.

PMID:
24635914
4.

Influence of changes in physical activity on frequency of hospitalization in chronic obstructive pulmonary disease.

Esteban C, Arostegui I, Aburto M, Moraza J, Quintana JM, Aizpiri S, Basualdo LV, Capelastegui A.

Respirology. 2014 Apr;19(3):330-8. doi: 10.1111/resp.12239. Epub 2014 Feb 2.

5.

Hypovitaminosis D correction and high-sensitivity C-reactive protein levels in hypertensive adults.

Carlson N, Mah R, Aburto M, Peters MJ, Dupper MV, Chen LH.

Perm J. 2013 Fall;17(4):19-21. doi: 10.7812/TPP/13-007.

6.

Early development of the vertebrate inner ear.

Magariños M, Contreras J, Aburto MR, Varela-Nieto I.

Anat Rec (Hoboken). 2012 Nov;295(11):1775-90. doi: 10.1002/ar.22575. Epub 2012 Oct 8. Review.

7.

Early otic development depends on autophagy for apoptotic cell clearance and neural differentiation.

Aburto MR, Sánchez-Calderón H, Hurlé JM, Varela-Nieto I, Magariños M.

Cell Death Dis. 2012 Oct 4;3:e394. doi: 10.1038/cddis.2012.132.

8.

AKT signaling mediates IGF-I survival actions on otic neural progenitors.

Aburto MR, Magariños M, Leon Y, Varela-Nieto I, Sanchez-Calderon H.

PLoS One. 2012;7(1):e30790. doi: 10.1371/journal.pone.0030790. Epub 2012 Jan 23.

9.

Autophagy during vertebrate development.

Aburto MR, Hurlé JM, Varela-Nieto I, Magariños M.

Cells. 2012 Aug 2;1(3):428-48. doi: 10.3390/cells1030428.

10.

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.

Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, Probstfield J, Ramachandran A, Riddle M, Rydén LE, Zinman B, Afzal R, Yusuf S, Gerstein H; TIDE Trial Investigators.

Diabetologia. 2012 Jan;55(1):36-45. doi: 10.1007/s00125-011-2357-4. Epub 2011 Oct 29.

PMID:
22038523
11.

The health, activity, dyspnea, obstruction, age, and hospitalization: prognostic score for stable COPD patients.

Esteban C, Quintana JM, Aburto M, Moraza J, Arostegui I, España PP, Aizpiri S, Capelastegui A.

Respir Med. 2011 Nov;105(11):1662-70. doi: 10.1016/j.rmed.2011.05.005. Epub 2011 Jun 23.

12.

Development of a decision tree to assess the severity and prognosis of stable COPD.

Esteban C, Arostegui I, Moraza J, Aburto M, Quintana JM, Pérez-Izquierdo J, Aizpiri S, Capelastegui A.

Eur Respir J. 2011 Dec;38(6):1294-300. doi: 10.1183/09031936.00189010. Epub 2011 May 12.

13.

COPD exacerbation: mortality prognosis factors in a respiratory care unit.

Aburto M, Esteban C, Moraza FJ, Aguirre U, Egurrola M, Capelastegui A.

Arch Bronconeumol. 2011 Feb;47(2):79-84. doi: 10.1016/j.arbres.2010.10.012. Epub 2011 Feb 12. English, Spanish.

14.

RAF kinase activity regulates neuroepithelial cell proliferation and neuronal progenitor cell differentiation during early inner ear development.

Magariños M, Aburto MR, Sánchez-Calderón H, Muñoz-Agudo C, Rapp UR, Varela-Nieto I.

PLoS One. 2010 Dec 28;5(12):e14435. doi: 10.1371/journal.pone.0014435.

15.

[Safety of inhaled corticosteroids in COPD].

Esteban C, Aburto M.

Arch Bronconeumol. 2010;46 Suppl 4:28-35. doi: 10.1016/S0300-2896(10)70030-2. Spanish.

16.

Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.

Hull RD, Schellong SM, Tapson VF, Monreal M, Samama MM, Nicol P, Vicaut E, Turpie AG, Yusen RD; EXCLAIM (Extended Prophylaxis for Venous ThromboEmbolism in Acutely Ill Medical Patients With Prolonged Immobilization) study.

Ann Intern Med. 2010 Jul 6;153(1):8-18. doi: 10.7326/0003-4819-153-1-201007060-00004.

PMID:
20621900
17.

BODE-Index vs HADO-score in chronic obstructive pulmonary disease: Which one to use in general practice?

Esteban C, Quintana JM, Moraza J, Aburto M, Aguirre U, Aguirregomoscorta JI, Aizpiri S, Basualdo LV, Capelastegui A.

BMC Med. 2010 May 24;8:28. doi: 10.1186/1741-7015-8-28.

18.

Impact of changes in physical activity on health-related quality of life among patients with COPD.

Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, Pérez-Izquierdo J, Aizpiri S, Aguirre U, Capelastegui A.

Eur Respir J. 2010 Aug;36(2):292-300. doi: 10.1183/09031936.00021409. Epub 2010 Jan 14.

19.

[A year's experience in an intermediate respiratory care unit].

Aburto M, Esteban C, Aguirre U, Egurrola M, Altube L, Moraza FJ, Capelastegui A.

Arch Bronconeumol. 2009 Nov;45(11):533-9. doi: 10.1016/j.arbres.2009.04.015. Epub 2009 Aug 3. Spanish.

20.

Classifying the severity of COPD: are the new severity scales better than the old?

Esteban C, Quintana JM, Egurrola M, Moraza J, Aburto M, Pérez-Izquierdo J, Basualdo LV, Capelastegui A.

Int J Tuberc Lung Dis. 2009 Jun;13(6):783-90.

PMID:
19460257
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk